Tumor reactivity assessment using clonal expression reveals tumor reactive CD8<sup>+</sup> T cell heterogeneity across solid tumors
<h4>Introduction</h4>Tumor infiltrating lymphocytes (TIL) drive the anti-tumor activity of a broad class of immunotherapies. <i>In situ</i> TIL are composed of T cells that recognize tumor antigens (Tumor Reactive T cells, or TRTs) as well as …
Read PDF